Renal-specific oxidoreductase biphasic expression under high glucose ambience during fetal versus neonatal development

Kidney International

Volumn 68, Issue 4, 2005, Pages 1670-1683

  Kanwar, Yashpal S ^a   Akagi, Shigeru ^b   Nayak, Baibaswata ^b   Sun, Lin ^b   Wada, Jun ^b   Xie, Ping ^b   Thakur, Arun ^b   Chugh, Sumant S ^b   Danesh, Farhad R ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

Apoptosis; Diabetic nephropathy; Glucose; Renal development; Renal specific oxidoreductase

Indexed keywords

GLUCOSE; MESSENGER RNA; OXIDOREDUCTASE; RENAL SPECIFIC OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EMBRYO; EMBRYONAL TISSUE; ENZYME ANALYSIS; ENZYME LOCALIZATION; FEMALE; FETUS; FETUS DEVELOPMENT; GLUCOSE ASSAY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; KIDNEY; KIDNEY CORTEX; KIDNEY DEVELOPMENT; KIDNEY MEDULLA; KIDNEY PARENCHYMA; KIDNEY TUBULE; MALE; MORPHOGENESIS; MOUSE; NEPHRON; NEWBORN; NEWBORN PERIOD; NICK END LABELING; NONHUMAN; NORTHERN BLOTTING; PERINATAL DEVELOPMENT; PERINATAL PERIOD; POLYMERASE CHAIN REACTION; PRENATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; URETER; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSE; KIDNEY; MALE; MICE; MICE, INBRED ICR; OXIDATIVE STRESS; OXIDOREDUCTASES; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 29144519240     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00611.x     Document Type: Article

References (55)

1. LEROITH D, TAYLOR SI, OLEFSKY JM: Diabetes Mellitus: A Fundamental and Clinical Text, 3rd ed., Philadelphia, Lippincott William & Wilkins, 2004, pp 1-1540
2. PARVING H-H, OSTERBY R, RITZ E: Diabetic nephropathy, in The Kidney, edited by Brenner BM, Philadelphia, WB Saunders Co., 2000, pp 1731-1773
3. BROWNLEE M: Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820, 2000
4. SHEETZ MJ, KING GL: Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 288:2579-2588, 2002
5. JAKUS V, RIETBROCK N: Advanced glycation end-products and the progress of diabetic vascular complications. Physiol Res 53:131-142, 2004
6. COHEN MP, CLEMENTS RS, HUD E, et al: Evolution of renal function abnormalities in the db/db mouse that parallels the development of human diabetic nephropathy. Exp Nephrol 4:166-171, 1996
7. WHITESIDE CI, DLUGOSZ JA: Mesangial cell protein kinase C isozyme activation in diabetic milieu. Am J Physiol Renal Physiol 282:F975-F980, 2002
8. LIN S, SAHAI A, CHUGH SS, et al: High glucose stimulates synthesis of fibronectin via a novel protein kinase C, Rap1b, and B-Raf signaling pathway. J Biol Chem 277:41725-41735, 2002
9. ZIYADEH FN: Mediators of diabetic renal disease: The case for TGF-β as the major mediator. J Am Soc Nephrol 15:S55-S57, 2004
10. CHEN S, JIM B, ZIYADEH FN: Diabetic nephropathy and transforming growth factor-β: Transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol 23:532-543, 2003
11. KIM YS, XU ZG, REDDY MA, et al: Novel interactions between TGF-β1 actions and the 12/15-lipoxygenase pathway in mesangial cells. J Am Soc Nephrol 16:352-362, 2005
12. KIM SL, KIM HJ, HAN DC, LEE HB: Effect of lovastatin on small GTP binding proteins and TGF-β1 and fibronectin expression. Kidney Int 58 (Suppl 77):S88-S92, 2000
13. SHARPE CC, HENDRY BM: Signaling: Focus on Rho in renal disease. J Am Soc Nephrol 14:261-264, 2003
14. SCHRAUWEN P, HESSELINK MK: Oxidative capacity, lipotoxicity and mitochondrial damage in type 2 diabetes. Diabetes 53:1412-1417, 2004
15. INOGUCHI T, SONTA T, TSUBOUCHI H, et al: PKC-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: Role of Vascular NAD(P)H oxidase. J Am Soc Nephrol 14:S227-S232, 2003
16. LI J-M, SHAH AM: ROS generation by nonphagocytic NADPH oxidase: Potential relevance in diabetic nephropathy. J Am Soc Nephrol 14:S221-S226, 2003
17. MASON RM, WAHAB NA: Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 14:1358-1373, 2003
18. ZIYADEH FN, SIMMONS DA, SNIPES ER, GOLDFARB S: Effect of myoinositol on cell proliferation and collagen transcription and secretion in proximal cells cultured in elevated glucose. J Am Soc Nephrol 1:1220-1229, 1991
19. NATH KA: The tubulointerstitium in progressive renal disease. Kidney Int 54:992-994, 1998
20. PHILLIPS AO: The role of renal proximal tubular cells in diabetic nephropathy. Curr Diab Rep 3:491-496, 2003
21. YANG Q, DIXIT B, WADA J, et al: Identification of a renal-specific oxido-reductase in newborn diabetic mice. Proc Natl Acad Sci USA 97:9896-9901, 2000
22. KANWAR YS, YANG Q, TIAN Y, et al: Relevance of renal specific oxidoreductase in tubulogenesis during mammalian nephron development. Am J Physiol Renal Physiol 282:F752-F762, 2002
23. CHUGH SS, WALLNER EI, KANWAR YS: Renal development in high-glucose ambience and diabetic embryopathy. Semin Nephrol 23:583-592, 2003
24. STUART RO, NIGAM SK: Developmental Biology of the kidney, in The Kidney, edited by Brenner BM, Philadelphia, WB Saunders Co., 2000, pp 68-92
25. HAMMERMAN MR: Growth factors in renal development. Semin Nephrol 15:291-294, 1995
26. ORELLANA SA, AVNER ED: Cell and molecular biology of kidney development. Semin Nephrol 18:233-243, 1998
27. ABRAHAMSON DR, HYINK RB, ST. JOHN PL, DANIEL TO: Origins and formation of microvasculature in the developing kidney. Kidney Int (Suppl 67):S7-S11, 1998
28. KANWAR YS, WADA J, LIN S, et al: Update of the role of extracellular matrix, its receptors and cell adhesion molecules in mammalian nephrogenesis. Am J Physiol Renal Physiol 286:F202-F215, 2004
29. MINER JH: Developmental biology of glomerular basement membrane components. Curr Opin Nephrol Hypertens 7:13-19, 1998
30. KASHIHARA N, WATANABE Y, MAKINO H, et al: Selective decreased de novo synthesis of glomerular proteoglycans under the influence of reactive oxygen species. Proc Natl Acad Sci USA 89:6309-6313, 1992
31. KANWAR YS, LIU ZZ, KUMAR A, WALLNER EI: Effect of glucose on renal development: Autoradiographic and biochemical studies. Lab Invest 76:671-681, 1997
32. KANWAR YS, KUMAR A, YANG Q, et al: Tubulointerstitial nephritis antigen: An extracellular matrix protein that selectively regulates tubulogenesis vs glomerulogenesis during mammalian renal development. Proc Natl Acad Sci USA 96:11323-11328, 1999
33. KANWAR YS, PAN X, LIN S, et al: Relevance of imprinted genes MEST and H19 to metanephric development in high glucose ambience. Kidney Int 63:1658-1670, 2003
34. LELONGT B, MAKINO H, DALECKI TM, KANWAR YS: Role of proteoglycans in renal development. Dev Biol 128:256-276, 1988
35. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 62:156-159, 1987
36. CAZENAVE C, STEIN CA, THUONG NT, et al: Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotide. Nucleic Acids Res 17:4255-5273, 1989
37. MOLEY KH, MUECKLER MM: Glucose transport and apoptosis. Apoptosis 5:99-105, 2000
38. MOLSTED-PEDERSEN L, TYGSTRUP I, PEDERSEN J: Congenital malformation in newborn infants of diabetic women. Lancet 1:1124-1126, 1964
39. KUCERA J: Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med 7:61-64, 1971
40. CHUNG CS, MYRIANTHOPOULOS NC: Factors affecting risks of congenital malformations. Birth Defects 11:23-27, 1975
41. ERIKSSON UL, CEDERBERG J, WENTZEL P: Mechanisms of diabetic embryopathy. The Diabetes Annual 12:359-396, 1999
42. KOUSSEFF BG: Gestational diabetes mellitus (class A): A human teratogen. Am J Med Genet 83:402-408, 1999
43. ADRA A, CORDERO D, MEJIDES A, et al: Caudal regression syndrome: Etiopathogenesis, prenatal diagnosis and prenatal management. Obstet Gynecol Surv 49:508-516, 1994
44. KASHIHARA N, SUGIYAMA H, MAKINO H: Implications of apoptosis in progression of renal diseases. Contrib Nephrol 139:156-172, 2003
45. CHANG TI, LOKEN MR: Genotoxicity and diabetic embryopathy: Impaired expression of developmental control genes as a cause of defective morphogenesis. Semin Reproductive Endocrinol 17:153-165, 1999
46. KANWAR YS, LIU ZZ, KUMAR A, et al: d-glucose-induced dysmorphogenesis of embryonic kidney. J Clin Invest 98:2478-2488, 1996
47. STEER DL, SHAH MM, BUSH KT, et al: Regulation of ureteric bud branching morphogenesis by sulfated proteoglycans in the developing kidney. Dev Biol 272:310-327, 2004
48. MAKINO H, SUGIYAMA H, KASHIHARA N: Apoptosis and extracellular matrix-cell interactions in kidney disease. Kidney Int (Suppl 77):S67-S75, 2000
49. HU E, CHEN Z, FREDRICKSON T, et al: Identification of a novel kidney-specific gene down-regulated in acute ischemic renal failure. Am J Physiol Renal Physiol 279:F426-F439, 2000
50. NATH KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20:1-17, 1992
51. NATH KA, NORBY SM: Reactive oxygen species and acute renal failure. Am J Med 109:665-678, 2000
52. ARNER RJ, PRABHU KS, THOMPSON JT, et al: myo-inositol oxygenase: Molecular cloning and expression of a unique enzyme that oxidizes myo-inositol and D-chiro-inositol. Biochem J 300:313-320, 2001
53. HANEDA M, KIKKAWA R, ARIMURA T, et al: Glucose inhibits myo-inositol uptake and reduces myo-inositol content in cultured rat glomerular mesangial cells. Metabolism 39:40-45, 1990
54. KAWA JM, PRZYBYLSKI R, TAYLOR CG: Urinary chiro-inositol and myo-inositol excretion is elevated in the diabetic db/db mouse and streptozotocin diabetic rat. Exp Biol Med 228:907-914, 2003
55. GROENEN PM, PEER PG, WEAVERS RA, et al: Maternal myo-inositol, glucose and zinc status is associated with the risk of offspring with spina bifida. Am J Obstet 189:1713-1719, 2003